Measured Wealth Private Client Group LLC Acquires 30 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Measured Wealth Private Client Group LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,579 shares of the healthcare conglomerate’s stock after purchasing an additional 30 shares during the quarter. UnitedHealth Group makes up approximately 0.4% of Measured Wealth Private Client Group LLC’s holdings, making the stock its 28th biggest holding. Measured Wealth Private Client Group LLC’s holdings in UnitedHealth Group were worth $1,276,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the business. Vanguard Group Inc. boosted its stake in UnitedHealth Group by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 83,860,515 shares of the healthcare conglomerate’s stock worth $44,150,045,000 after acquiring an additional 250,291 shares during the last quarter. Wellington Management Group LLP boosted its stake in UnitedHealth Group by 2.1% during the 3rd quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock worth $12,715,790,000 after acquiring an additional 527,526 shares during the last quarter. Capital Research Global Investors boosted its stake in UnitedHealth Group by 2.2% during the 4th quarter. Capital Research Global Investors now owns 15,122,203 shares of the healthcare conglomerate’s stock worth $7,961,369,000 after acquiring an additional 324,733 shares during the last quarter. Capital International Investors boosted its stake in UnitedHealth Group by 4.8% during the 4th quarter. Capital International Investors now owns 11,860,985 shares of the healthcare conglomerate’s stock worth $6,244,158,000 after acquiring an additional 542,424 shares during the last quarter. Finally, Norges Bank acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $5,802,231,000. Institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have commented on UNH shares. Morgan Stanley dropped their target price on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a report on Friday, April 5th. JPMorgan Chase & Co. lifted their price objective on shares of UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a report on Thursday, May 30th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a report on Friday, April 19th. Truist Financial reiterated a “buy” rating and issued a $600.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 17th. Finally, Bank of America reiterated a “buy” rating and issued a $675.00 price objective on shares of UnitedHealth Group in a report on Thursday, March 7th. Three research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average target price of $579.74.

UnitedHealth Group Trading Up 0.7 %

Shares of UnitedHealth Group stock opened at $498.13 on Wednesday. The firm has a 50-day moving average of $498.40 and a 200-day moving average of $501.35. The stock has a market cap of $458.47 billion, a PE ratio of 30.45, a PEG ratio of 1.48 and a beta of 0.60. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. UnitedHealth Group’s quarterly revenue was up 8.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $6.26 earnings per share. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.55 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.69%. The ex-dividend date of this dividend was Monday, June 17th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s payout ratio is 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.